Pancreatic Cancer Research

ResearcherThe Royal Free HospitalActive in the last 2 years

Pilar Acedo Núñez

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4815-6090; OpenAlex author ID A5056512778. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
36
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 3 papers

Papers 9

  1. Identification of serum protein biomarkers for pre-cancerous lesions associated with pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/1878-0261.70213↗
  2. Associations Between Routinely Measured Biomarkers and Pancreatic Cancer Risk in Individuals with Type 2 Diabetes Pre- and Post-Diagnosis. Co-author DOI 10.3390/cancers18091428↗
  3. High-fat diet imprints a macrophage-tumor CAMP-P2RX7 axis driving pancreatic cancer initiation, plasticity and metastasis Co-author DOI 10.64898/2026.02.10.703309↗
  4. Breakthroughs in nanoparticle-based strategies for pancreatic cancer therapy. Last author DOI 10.1016/j.bcp.2024.116685↗
  5. Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals. First author DOI 10.1016/j.bpg.2025.101974↗
  6. Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection. Co-author DOI 10.1371/journal.pcbi.1012408↗
  7. Smart Nanoparticles as Advanced Anti-Akt Kinase Delivery Systems for Pancreatic Cancer Therapy. Last author DOI 10.1021/acsami.1c14592↗
  8. The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies. Last author DOI 10.3390/jcm10040566↗
  9. Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer. Co-author DOI 10.3390/cancers11091372↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephen P. Pereira · 5 shared papers, 2019–2026 · strength 0.93
  2. Alexander Ney · 2 shared papers, 2021–2024 · strength 0.36
  3. Aleksander M. Bogdanski · 1 shared paper, 2025 · strength 0.33
  4. Monique Esther van Leerdam · 1 shared paper, 2025 · strength 0.33
  5. Derk C.F. Klatte · 1 shared paper, 2025 · strength 0.33
  6. Michael B. Wallace · 1 shared paper, 2025 · strength 0.33
  7. Andrés García-Sampedro · 2 shared papers, 2021 · strength 0.32
  8. Sara Escalera-Anzola · 1 shared paper, 2025 · strength 0.30
  9. Mieke Van Hemelrijck · 1 shared paper, 2026 · strength 0.30
  10. Debashis Sarker · 1 shared paper, 2026 · strength 0.30
  11. Ziying Zhang · 1 shared paper, 2026 · strength 0.30
  12. Aida Santaolalla · 1 shared paper, 2026 · strength 0.30
  13. Hannah Mearns · 1 shared paper, 2026 · strength 0.28
  14. Sara R. Zanivan · 1 shared paper, 2026 · strength 0.28
  15. Kevin M. Ryan · 1 shared paper, 2026 · strength 0.28
  16. Patricia Sancho Andrés · 1 shared paper, 2026 · strength 0.21
  17. Beatriz Parejo-Alonso · 1 shared paper, 2026 · strength 0.21
  18. Antonio Agostini · 1 shared paper, 2026 · strength 0.21
  19. Sonia Alcalá · 1 shared paper, 2026 · strength 0.21
  20. Lívia Archibugi · 1 shared paper, 2026 · strength 0.21
  21. Juan Carlos López-Gil · 1 shared paper, 2026 · strength 0.21
  22. Ana Galván-del-Rey · 1 shared paper, 2026 · strength 0.21
  23. Mariano Barbacid · 1 shared paper, 2026 · strength 0.21
  24. Claudio Luchini · 1 shared paper, 2026 · strength 0.21
  25. Carmen E. Guerra · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.